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Non.H-2 genes alter the H-2 determined susceptibilities in immune
complex nephritis. These experiments examined the effects of genes
outside of the H-2 region on disease susceptibility and pathogenesis.
Four strains of mice with the susceptible H-2 type, H-2", but different
non-H-2 genes were studied. BlO.D2, Balb/c, NZB, and DBA/2J mice
were injected with 4mg of apoferritin i.p. q.d. for 28 days. BlO.D2 and
Balb/c mice developed proliferative and crescentic glomerulonephritis.
NZB mice developed proliferative and crescentic glomerulonephritis
with wire loop lesions suggestive of lupus. DBA/2J mice developed only
minimal mesangial proliferation without crescents or necrosis. Electron
microscopy showed subepithelial and mesangial deposits in BlO.D2,
moderate subepithelial and mesangial deposits in Balb/c, and marked
mesangial, subendothelial and subepithelial deposits in NZB. Immuno-
fluorescence demonstrated the presence of lgG, 1gM, C3 and apoferritin
in these deposits. The DBA/2J mice had only minimal mesangial
deposits by immunofluorescence and electron microscopy. These ex-
periments demonstrate that non-H-2 genes alter the H-2" determined
disease susceptibility seen in H-2 congenic mice. NZB genes can alter
the disease so that lupus-like lesions develop and DBA/2J genes can
substantially ameliorate the disease.
Certain types of human immune complex glomerulonephritis
occur more commonly in patients with particular human leuko-
cyte antigens (HLA). Examples include membranoproliferative
glomerulonephritis [1], membranous glomerulonephritis [2] and
Berger's IgA nephropathy [3]. The association between genes
in the major histocompatibility complex and the development of
human glomerulonephritis is not absolute, suggesting that other
factors may also be important.
The work of several investigators suggested a role for genes
in the H-2 region in an animal model of immune complex
glomerulonephritis (Apo-ICGN) which is induced in mice with
horse spleen apoferritin [4, 5]. The importance of the H-2 region
in determining susceptibility was definitively demonstrated
using the H-2 congenic strains BlO (H-2'i, BIO.BR (H2k) and
B10.D2 (H2d) which share all the same genes except in the H-2
region where they are divergent. These experiments clearly
demonstrated a role for the H-2 genes because the B10 mice
were essentially normal, the B 10.BR mice had mesangial pro-
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liferation and the BlO.D2 mice had dramatic necrotizing and
proliferative glomerulonephritis [6].
In addition, a role for non-H-2 genes in the pathogenesis of
Apo-ICGN was suggested by two studies. Apo-ICGN was
studied in a series of H2k mice with the moderately susceptible
H-2 type (H2k) and different non-H-2 genes. Differences in
disease susceptibility were observed with CBA and BI0.BR
being susceptible and C3H being resistant [7]. It would be
beneficial to look at the effects of non-H-2 genes in the more
susceptible H2d strains. The gene for CS, which is not coded
for in the H-2 region, is important in the pathogenesis of
Apo-ICGN because CS deficient mice with a highly susceptible
H-2 type were less susceptible to the glomerular injury induced
by the injection of horse spleen apoferritin than were CS
sufficient mice [4].
The purpose of these studies was to further examine the role
of genes outside of the H-2 region in mice with the most
susceptible H-2 type, H2d. For these experiments four dif-
ferent H2d strains were chosen; Balb/c, DBA/2J, NZB and
BlO.D2.
Methods
Mice
Four strains of H-2" mice with different non-H-2 genes were
studied. Five- to six-week-old male BI0.D2/nsnJ, Balb/cByJ,
NZB/BlnJ and DBA/2J mice were purchased from the Jackson
Laboratory, Bar Harbor, Maine, USA. The mice were fed
standard chow, had unlimited access to water and were main-
tained in the animal care facility of the SUNY Health Sciences
Center at Syracuse. Portions of the data on the Bl0.D2 mice
have been previously published [6].
Protocol
Mice were allowed to acclimate to the animal care facility for
one to two weeks and were seven to eight weeks old at the
beginning of the study. Animals in the apoferritin group re-
ceived 4 mg of horse spleen apoferritin (Sigma Chem. Co., St.
Louis, Missouri, USA) in 0.2 cc of normal saline i.p. q.d. for
twenty-eight days. Animals in the control group received 0.2 cc
of normal saline containing small amounts of cadmium chloride
to adjust for cadmium contained in the apoferritin. On day 32,
the mice were sacrificed by cervical dislocation. If a mouse
became moribund prior to day 32, it was sacrificed and the data
utilized if adequate tissues could be obtained.
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On days 0 and 14 blood was obtained from the tail vein. At
the time of sacrifice, blood was obtained by cardiac puncture.
Serum was separated and stored at —70°C. On days 0, 14, and
28, twenty-four hour urine collections were obtained by placing
the animals in metabolic cages with unlimited access to water
but no access to food. Urine was centrifuged to remove
sediment and frozen at —70°C until the assays were performed.
Assays
Blood urea nitrogen was assayed by the urease technique [8]
and urinary protein was measured by the Coomassie blue dye
binding technique [9]. Anti-apoferritin IgG levels were deter-
mined by an enzyme-linked immunosorbent assay (ELISA)
technique as previously described [61.
Anti-double stranded DNA antibodies were measured by
ELISA [101. Single stranded DNA (ssDNA) and double
stranded DNA (dsDNA) was prepared as described [II]. Im-
mulon II plates (Dynatech, Santa Monica, California, USA)
were coated with 50 diwe11 of poly-1-ly sine at 50 g/ml (Sigma),
incubated at room temperature for 30 minutes, and washed
three times in Tris-buffered saline (TBS). The wells were then
filled with 50 pilwell of ssDNA or dsDNA at a concentration of
2.5 pg/ml and incubated for two hours at room temperature.
The plates were washed twice with TBS and incubated with 50
pg/mI of poly-l-glutamate (Sigma) for one hour at room temper-
ature. The wells were washed and left filled with TBS at 4°C
until ready for use. At the time of the assay, wells were washed,
filled with 50 d of phosphate buffered saline (PBS) with 3%
BSA for one hour and then washed twice with PBS-Tween and
twice with PBS. Serum was diluted 1/800 in PBS containing 1%
BSA and 0.05% Tween and renal eluates were adjusted to 10 sg
of protein per ml. Forty microliters were added in duplicate to
the ssDNA or dsDNA coated plates. Positive controls included
sera and renal eluate from NZB X SWR F mice which produce
high titers of anti-double stranded DNA antibodies. Negative
controls included Balb/c and AKR serum. After a two hour
incubation at room temperature the plates were washed with
PBS-Tween and PBS. An alkaline phosphatase conjugated
anti-mouse IgG and 1gM (Boehringer-Manheim, Indianapolis,
Indiana, USA) was added at 1/2000 and incubated overnight at
4°C. The plates were washed twice with PBS and 1% Tween,
twice with PBS and the reaction was developed with para-
nitrophenyl phosphate at 5 mg/mI (Sigma). The color reaction
was read after 30 minutes on an Microelisa autoreader
(Dynatech, Santa Monica, California, USA) at 405 nm.
Immuno globulin elution
Immunoglobulin was eluted from the kidneys by a variation
of the technique of Woodroffe and Wilson [12]. At the time of
sacrifice kidneys were snap frozen in OCT compound (Lab Tek
Products, Naperville, Illinois, USA) and stored at —70°C. At
the time of extraction, the kidneys were thawed and washed
with PBS, then homogenized for 15 seconds in a tissue homog-
enizer (Tekmar, Cincinnati, Ohio, USA), and extensively
washed in PBS at 4°C until the supernatant had an O.D.280 of
less than 0.050. The homogenate was suspended in 0.5 cc of
0.02 M citrate buffer (pH 3.2) at a ratio of at least 10 mIs per
mg of tissue, and incubated at 37°C with shaking for three
hours. The suspension was centrifuged at 1500 g for 20 minutes
and the supernatant was dialyzed against 0.02 M PBS with 0.1%
NaN3.
Pathology
The kidneys were removed at the time of sacrifice after
cardiac puncture. For light microscopy tissue was fixed in
buffered formalin, embedded in paraffin, sectioned at 3 to 5 tm,
and stained with periodic acid-Schiff as well as hematoxylin and
eosin.
For electron microscopy, tissue was fixed in buffered 2.5%
glutaraldehyde, stained with osmium tetroxide, embedded in
Araldite 502 (Electron Microscopy Sciences, Fort Washington,
Pennsylvania, USA), sectioned at 60 nm on a Nova microtome
(LKB, Gaithersburg, Maryland, USA) and stained with uranyl
acetate and lead citrate.
Fresh tissue for immunofluorescence microscopy was snap
frozen in OCT compound (Lab Tek Products) and stored at
—70°C. Three micrometer sections were prepared with a
Damon/IEC microtome (International Equipment Corp., Need-
ham Hts., Massachusetts, USA) and stained with fluorescein
isothiocyanate conjugated goat anti-mouse IgG, 1gM, IgA, C3
and albumin (Cooper Biomedical Inc., Malvern, Pennsylvania,
USA) as described previously [6]. To detect the presence of
apoferritin, kidney sections were stained with rhodamine con-
jugated mouse anti-horse ferritin (Jackson Immunoresearch
Lab., Inc., Avondale, Pennsylvania, USA) which reacts with
apoferritin by ELISA assay.
All biopsies were interpreted and scored in a blinded fashion.
Light microscopy was graded as normal, 0; mild proliferation,
1; marked proliferation without crescents, 2; marked prolifera-
tion with less than 25% crescents, 3; and marked proliferation
with greater than 25% crescents, 4.
Statistics
All data are recorded as the mean SEM. For continuous
variables with comparisons between two groups, Student's
two-tailed t-test was used. For continuous variables with com-
parisons between more than two groups analysis of variance
and Scheffe's F-test were used. Discontinuous data such as the
pathologic scores were compared by the Wilcoxon rank sum
test [13].
Results
Pathology
There were marked differences in the glomerular pathology
between the four strains. All twelve of the apoferritin injected
Balb/c mice were abnormal with 50% of the mice having
crescents. These crescents were present in <25% of glomeruli
giving a pathology score of 3. Eleven of the twelve had marked
mesangial proliferation (Fig. lA) and the twelfth had mild
mesangial proliferation. Casts of protein and red cells were also
seen within the renal tubules. There were eight saline-injected
controls, all of which survived the protocol and had no signif-
icant lesions.
The NZB mice also had very dramatic pathologic abnormal-
ities. Of the twelve apoferritin injected mice that started the
protocol, only seven survived for the full 32 days. Material was
available for pathologic examination in eleven of these mice.
Eight of eleven mice had crescents, and four of these had
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Fig. 1. Light microscopy in apoferritin treated mice. The
light microscopy is illustrated for all of the strains studied.
(A) BalbIc mice demonstrated marked mesangial
proliferation. Crescents (not illustrated here) were seen in
<25% of glomeruli in half of the mice. These changes are
very similar to but not quite as severe as those previously
seen in B1O.D2 mice [6]. (B) NZB mice demonstrated
marked mesangial and endocapillary proliferation as well as
wire loop lesions. Crescents were seen in 67% of the NZB
mice with half having <25% and half having >25%
crescents. There also were areas of necrosis and
polymorphonuclear infiltration. (C) The DBA/2J mice had
only minimal disease and the glomerulus illustrated here is
essentially normal. Stained with hematoxylin and eosin,
approx. 800 x.
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Fig. 2. Light microscopy scores. The light microscopy scores for the
three strains studied are illustrated. The Bl0.D2 mice [61 are included
for comparison. Balb/c, NZB and B lO.D2 mice all had significantly
higher pathology scores (*P < 0.001) than the DBA/2J mice. Normal
saline injected controls score 0 or 1.
extensive crescents in >25% of glomeruli giving a pathology
score of 4. In addition there was tubular atrophy and occasional
casts. There was also mesangial and endocapillary prolifera-
tion, extensive areas of necrosis and infiltration with polymor-
phonuclear leukocytes. The other three mice had marked
proliferation but no crescents. The most intriguing finding,
however, was the presence of massive deposits within the
glomerular basement membrane suggestive of "wire loop"
lesions as might be seen in systemic lupus erythematosus (Fig
lB). There were eight saline-injected control NZB mice, of
which seven survived the protocol and had only minimal
mesangial proliferation.
Apoferritin injected DBA/2J mice had very modest lesions
(Fig 1C). Only one of twelve had marked mesangial prolifera-
tion and none of the mice had any crescents. All of the other
mice had only minimal mesangial proliferation. Pathologic
scores for the apoferritin-injected DBAI2J mice did not differ
significantly from the seven saline-injected DBA/2J mice who
survived the protocol.
Eight of the ten apoferritin injected Bl0.D2 mice who sur-
vived also had severe lesions with diffuse endocapillary and
mesangial proliferative glomerulonephritis [61. The B 10. D2
mice had somewhat more crescents, necrosis, interstitial infil-
trate and casts than the Balb/c. All ten of the saline injected
BlO.D2 mice survived and had no significant lesions [6].
Mean pathologic scores of apoferritin treated mice were 2.4
0.19 for the Balb/c, 3.1 0.25 for the NZB and 1.33 0.10
for the DBAJ2J. The Bl0.D2 mice had a score of 3.25 0.25 [6].
Balb/c, NZB and Bl0.D2 mice all had significantly higher
pathology scores (P < 0.001) than the DBA/2J (Fig. 2) and their
saline injected controls (P < 0.01). Apoferritin-injected DBA/2J
mice were not significantly different than their saline injected
controls. Since the scoring system does not account for the wire
loops seen in the NZB mice, they scored similarly to the
BlO.D2 and Balb/c strains. However, the pathology in apofer-
ritin-treated NZB kidneys was qualitatively quite different than
the other groups.
Immunofluorescence microscopy revealed the presence of
heavy deposits of IgG, 1gM and C3 in the glomeruli of the
Balb/c and NZB mice with severe disease (Fig. 3. A-B) as was
previously described in BlO.D2 mice [6]. In Balb/c the deposits
were seen in the mesangial and capillary loop regions. In NZB
mice the deposits were also present in the capillaries and the
mesangium. Additionally, staining with rhodamine-conjugated
anti-horse spleen ferritin which reacts with apoferritin revealed
the presence of apoferritin within the deposits in the Balb/c
strain as was described in the Bl0.D2 [6]. In the NZB mice,
apoferritin localized to the wire loops (Fig. 3C).
The precise location of these deposits was determined by
electron microscopy. The Balb/c mice had deposits primarily in
the mesangial, perimesangial, and subepithelial regions (Fig.
4A). The NZB mice had many large deposits in the mesangium,
subepithelial and subendothelial positions (Fig. 4B). The DBA/
2J mice had only small mesangial deposits (Fig, 4C). In the
B10.D2 mice the deposits were in the mesangial and subepithe-
hal position [6].
IgG antiapoferritin antibody
The IgG antiapoferritin antibody responses were measured
by ELISA (Fig. 5). Prior to injections, NZB mice had signifi-
cantly elevated anti-apoferritin IgG levels compared to the
other strains (P < 0.05, vs. all other strains, Scheffe F-test),
although the magnitude of this elevation was not great. By the
fourteenth day, the antibody levels were rising in all strains but
with marked elevations in the B10.D2 mice (P < 0.05 vs. all
other strains, Scheffe F-test). At sacrifice the antibody levels
had actually decreased in the B10.D2 mice and to some degree
in the DBA/2J. However, the levels in the Balb/c and NZB mice
continued to rise. The levels at day 32 were significantly
elevated for the NZB (P < 0.05, vs. all other strains, Scheffe
F-test).
In addition, the anti-apoferritin IgG levels in apoferritin
versus saline injected animals were significant for all the strains
studied (P < 0.05, Student's 1-test) and the anti-apofemtin IgG
levels in the saline-injected NZB mice exceeded the levels in
the apoferritin injected DBA/2J mice at day 32 (P < 0.025,
Student's f-test).
Anti-nuclear antibodies
Anti-ssDNA and anti-dsDNA antibodies were also measured
by ELISA in the NZB mice (Fig. 6A). There was a rise in the
level of the serum anti-dsDNA antibodies in seven of nine
apoferritin-injected mice. Two mice did not have elevated
levels of anti-double stranded DNA antibodies. One was mor-
ibund and had a markedly elevated blood urea nitrogen. If that
mouse is excluded, the data is significant (P < 0.02). The other
mouse without elevated anti-double stranded DNA antibodies
in the serum had the least glomerulonephritis of the apoferritin
injected group with a pathology score of two. Serum anti-
ssDNA antibody levels were not significantly elevated in NZB
(data not shown). Serum from the other strains was also tested
for anti-ssDNA and anti-dsDNA antibodies. Balb/c had no
elevations of either antibody. For B10.D2 and DBAI2J the
serum anti-ss or anti-ds DNA antibodies in the serum were both
elevated relative to saline injected controls.
Renal eluate anti-dsDNA from NZB is illustrated in Figure
6B and the renal eluate anti-ssDNA from NZB is shown in
Figure 6C. For both autoantibodies the data is significant (P <
0.01). No significant elevations could be found in the renal
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Fig. 3. Immunofluorescence microscopy in apoferritin treated
mice. (A) Staining with FITC goat anti-mouse lgG demonstrates
both mesangial and capillary loop deposits (arrow) in a Balb/c
mouse as was seen in the B10.D2 mice [6]. (B) Predominantly
mesangial staining can be seen in this illustration from an NZB
mouse. The DBA/2J mice had minimal to no staining. Staining
with a rhodamine conjugated mouse anti-horse ferritin demon-
strated the presence of apoferritin in the immune complexes in
Balb/c and NZB mice. (C) In the NZB, apoferritin was seen in the
mesangium but was particularly dramatic in the wire loops.
Approx. 1100 x for A and 700 x for B and C.
eluate anti-ss or anti-dsDNA antibodies from B10.D2, Balb/c or
DBA/2J (data not shown).
Blood urea nitrogen and urinary protein
Blood urea nitrogen values for all groups are presented in
Figure 7. Although each strain started at a somewhat different
blood urea nitrogen, only B10.D2 and NZB showed a rise in the
level of the blood urea nitrogen during apoferritin injection and
neither rise was statistically significant.
Twenty-four-hour urinary protein excretions are illustrated in
Figure 8. Once again, although each strain started at a some-
what different level, only Bl0.D2 and NZB mice had substantial
rises in their twenty four hour protein excretion. Of these, only
the rise in the BlO.D2 mice were of significance (P < 0.05 for
BlO.D2 vs. DBA/2J at week 4).
Discussion
Some forms of human glornerulonephritis occur more com-
monly in patients with certain HLA antigens [1—31. However,
not all patients with a specific HLA allele will develop the
disease. For example, although patients with HLA-DR3 are at
higher risk of developing idiopathic membranous glomerulone-
phritis, most persons with HLA-DR3 will not develop membra-
nous glomerulonephritis [2]. This may be because HLA-DR3 as
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Fig. 4. Electron microscopy in apoferritin treated mice. (A)
The glomeruli in the Balb/c mice reveal subepithelial
deposits (arrows). There were also mesangial and
perimesangial deposits which are not seen in this
illustration. (B) The NZB mice show massive
subendothelial, mesangial and occasional subepithelial
deposits. (C) The DBAI2J mice had only small mesangial
deposits. Approx. 23000 x for A and B, and 8000 X for C,
'I.
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Fig. 5. Anti-apoferritin antibody levels. The antibody levels were
determined semiquantitatively by ELISA. The data for the Bl0.D2
mice [6] are included for comparison. At day 0, the levels were slightly
elevated in the NZB mice vs. the other strains (P < 0.05). The levels
had risen by day 14 in all strains but the elevation in the BlO.D2 was the
most marked (P < 0.05 vs. the other strains). By Day 32 the levels in the
BlO.D2 and the DBA/2J mice had decreased but the NZB and Balb/c
mice continued to rise and this was significant for the NZB mice (P <
0.05 vs. all other strains). Saline injected controls average less than 2
g/ml with the exception of the NZB mice in which the saline injected
controls had 8.5 1.1 gIml. The anti-apoferritin antibody levels are
significantly elevated in each strain in the apoferritin injected vs. the
normal saline injected controls (P < 0.05). The NZB saline injected
controls are elevated vs. the DBA/2J apoferritin-injected mice at day 32(P < 0.025). Symbols are: Balb/c (Efl, NZB (•), DBA/2J (U), and
B10.D2 (c).
defined serologically may be quite diverse at the DNA level and
disease risk may be associated with only some subtypes of
HLA-DR3 as demonstrated in diabetes [14]. It is also possible
that other factors such as genes outside of the major histocom-
patibility complex may be important in the pathogenesis of
human glomerulonephritis.
The purpose of the current experiments was to study a series
of inbred mice with the genes in the H-2 region known to be at
high risk for developing Apo-ICGN, that is, H-2'' [6], but with
entirely different non-H-2 genes. In the present studies, Balb/c
mice also developed severe ICGN with crescents. The glomer-
uli had deposition of IgG, C3 and apoferritin. Compared to
BlO.D2 mice, Balb/c mice had somewhat lower pathologic
scores although the differences were not significant. In addition,
Balb/c mice did not develop proteinuria or azotemia, suggesting
that pathologic abnormalities are a more sensitive indicator of
glomerular pathology in this disease model. Previous work with
Balb/c has shown similar findings [5, 15, 16] although the degree
of pathologic abnormalities was somewhat different.
DBAI2J mice behaved in a quite different manner despite
having the susceptible H-2 genotype, H2d. These mice devel-
oped only minimal pathologic lesions or were within normal
limits and the pathology scores did not differ from saline
injected controls. In addition, DBA/2J mice had normal physi-
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Fig. 7. Blood urea nitrogen. The blood urea nitrogen was elevated at
week four in the B10.D2 and NZB mice but the elevations were not
statistically significant. Symbols are: Balb/c (D), NZB (•), DBA/2J (i),
and B10.D2 ().
ological parameters and developed only a modest antibody
response compared to the other three strains studied. Interest-
ingly, B10.BR (H-2") mice, which develop mesangial prolifera-
tion in response to apoferritin [6], actually have antibody levels
somewhat lower than the levels in the DBA/2J mice, suggesting
that other factors such as antibody avidity [16] or isotype may
be playing a role. It is clear from this data that the H2d
genotype is not sufficient for the development of severe Apo-
ICGN. Genes outside of H-2 must also play a role.
This phenomenon occurs in other animal disease models. In
murine interstitial nephritis, Balb/c and BlO.D2 mice are sus-
ceptible, but DBA/2J mice are not [17]. Neilson and coworkers
suggested that interactions between the H-2K locus and the
Igh-l locus (which codes for IgG2a) were important in the
pathogenesis of this disease. A similar phenomenon was de-
scribed in experimental allergic orchitis [181. In murine collagen
II autoimmune arthritis, disease susceptibility has been associ-
ated with genes within H-2 [19], and with non-H-2 genes such as
Igh-I and C5. Indeed, the essential role that C5 plays in
Apo-ICGN was also shown [4j. In humans the influence of
genes outside of the major histocompatibility complex has been
demonstrated for the Gm loci on chromosome 14, which code
for human immunoglobulin heavy chains, in multiple sclerosis
[20] and lupus nephritis [21].
The glomerular lesions in NZB mice were in many ways the
most interesting. These mice developed severe proliferative
ICGN with massive deposits similar to the "wire loop" lesions
seen in human lupus glomerulonephritis. These deposits were
large and located in the subepithelial and subendothelial posi-
tions. In other strains studied by this laboratory, such extensive
subendothelial deposits have not been seen. These deposits
Week
FIg. 8. Urinary protein excretion. Only the BI0.D2 and NZB mice had
elevated levels of 24-hour urinary protein excretion, and of these only
the BlO.D2 were significant (P < 0.05 for the BlO.D2 vs. DBA/2J at
week 4). Symbols are: Balb/c (D), NZB (•), DBAI2J (s), and Bl0.D2
(c).
contained large amounts of apoferritin by immunofluorescence
microscopy. In addition to the pathological abnormalities sug-
gesting active lupus nephritis, renal eluates from NZB mice
contained anti-ssDNA and dsDNA antibodies.
NZB mice spontaneously develop autoimmune hemolytic
anemia and anti-nuclear antibodies after three months of age
[22]. In addition, glomerulonephritis develops spontaneously in
NZB mice. However, severe glomerulonephritis is not seen
until late in life [23] and significant azotemia is seen only in
elderly mice [22]. In our experiments, no significant glomeru-
lonephritis or proteinuria was seen in the normal saline controls
at the time of sacrifice at the age of three months. The saline
injected controls did not develop autoantibodies in serum or
kidneys.
Several phenomena appear to accelerate the development of
glomerulonephritis in NZB mice. For example, the NZB X
NZW F1 hybrid develops fulminant lupus nephritis [24] as do
the NZB X SWR F1 hybrids [25]. Infection with lymphocytic
choriomeningitis virus [26] and polyoma virus [27] was associ-
ated with more aggressive glomerulonephritis and elevated
anti-nuclear antibodies. Injections of the synthetic double
stranded ribonucleic acid, polyinosinic-polycytidylic acid, also
accelerates the disease [28]. In non-autoimmune mice, autoanti-
bodies and glomerulonephritis can be produced by injections
with lipopolysaccharide [29, 30].
In the current studies, the acceleration of the development of
a glomerular lesion suggestive of lupus nephritis and the devel-
opment of autoantibodies came about as a result of the injection
of an irrelevant antigen, apoferritin. The mechanisms of this
phenomenon are not clear. Some authors have suggested that
the B cells of the NZB mouse are hyperactive [31] and the data
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in these studies would support that notion. NZB mice had the
highest antiapoferritin antibody levels at the time of sacrifice of
any strain we have studied. In addition, NZB mice had the
highest levels of antiapoferritin antibody prior to immunization
and saline-injected NZB mice had higher levels of antiapofer-
ritin antibody on day 32 than apoferritin injected DBA/2J.
Whether development of large deposits in the subepithelial and
subendothelial spaces in these mice is a function of the ex-
tremely high antibody levels or some other factor such as
antibody avidity [161, charge [32], or isotype [33] is not clear.
Likewise, the role of the anti-dsDNA and anti-s sDNA antibod-
ies in the pathogenesis of Apo-ICGN in NZB mice remains
unclear. The presence of large amounts of apoferritin in the
NZB kidneys suggests that apoferritin- anti-apoferritin immune
complexes were involved in the pathogenesis of the glomerulo-
nephritis. In addition, the presence of serum anti-nuclear anti-
bodies in B10.D2 and DBAI2J suggests that these antibodies
may form as a result of the immunization even in strains not
predisposed to lupus. This has been seen in hyperimmunized
mice [34] and mice immunized against tubercle bacillus [35].
Humans with chronic infections also develop autoantibodies
[36]. However, in these studies only the NZB mice deposit
these antibodies in their kidneys. We are currently examining
the isotype classes and spectrotypes of these antibodies to
identify any differences in NZB, BlO.D2, DBA/2J and Balb/c
which may have contributed to the development of lupus-like
lesions in NZB mice.
A number of non-H-2 genes might be important in determin-
ing disease susceptibility. Genes coding for the T cell receptor,
immunoglobulin allotypes, such as Igh-l, minor histocompati-
bility loci coded for on other chromosomes than chromosome 6,
and complement loci [4] may all play a role.
Despite the dramatic changes that occur pathologically in
these kidneys, the blood urea nitrogens were not significantly
elevated. Perhaps this occurred because blood urea nitrogen is
a poor marker of glomerular filtration rate. Another possibility
is that the most azotemic mice died prematurely. Likewise,
with the exception of the BlO.D2 mice, the animals did not have
proteinuria.
Genes in the H-2 region are crucially important in determin-
ing the susceptibility to Apo-ICGN and the pathology that
results [6]. The present study demonstrates that genes outside
of the major histocompatibility complex also can modify the
expression of this disease. Non-H-2 genes in the DBA/2J strain
can virtually eliminate the disease. Which non-H-2 genes are
important in this effect remains to be determined. NZB back-
ground genes can alter the expression of Apo-ICGN so that it
appears pathologically similar to lupus nephritis and is associ-
ated with the development of autoantibodies and severe gb-
merulonephritis. Genes in the Balb/c background do not alter
the expression of Apo-ICGN as described in the BlO.D2 mouse
[6]. Susceptibility to Apo-ICGN is therefore dependent upon
H-2 and non-H-2 genes.
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